NCT01498900 An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01497600 Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01497587 Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan Status COMPLETED Phase PHASE1
NCT01497574 Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01497561 Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01497535 Within-subject Variability of Insulin Detemir in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01496430 Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes Status TERMINATED Phase PHASE3
NCT01493388 To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1 Status COMPLETED Phase N/A
NCT01492218 Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction Status COMPLETED Phase N/A
NCT01492205 NovoLet® Acceptance Study Within the Hospital Practise in Indonesia Status COMPLETED Phase N/A
NCT01492166 Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01492153 NovoLet® Surveillance Study on Using Human Insulin System in Indonesia Status COMPLETED Phase N/A
NCT01490658 Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01490099 Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01489644 Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01487811 Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01487798 Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE4